EFFECTS OF LINOLEIC AND OLEIC-ACID ANILIDES ON PROSTACYCLIN SYNTHESISAND FIBRINOLYTIC PROFILE OF HUMAN ENDOTHELIAL-CELLS IN CULTURE - RELEVANCE TO THE TOXIC OIL SYNDROME
C. Decastellarnau et al., EFFECTS OF LINOLEIC AND OLEIC-ACID ANILIDES ON PROSTACYCLIN SYNTHESISAND FIBRINOLYTIC PROFILE OF HUMAN ENDOTHELIAL-CELLS IN CULTURE - RELEVANCE TO THE TOXIC OIL SYNDROME, Toxicology, 81(3), 1993, pp. 181-194
We evaluated the effects of fatty-acid anilides (FAA) on prostacyclin
(PGI2) synthesis and on the fibrinolytic properties of human umbilical
vein endothelial cells. Preincubation of endothelial cells with oleic
- and linoleic-anilides (OAA and LAA, respectively) resulted in a time
- and concentration-dependent inhibition of ionophore A23187- and thro
mbin-induced PGI2 synthesis. However, no significant effects of FAA on
arachidonic acid-induced PGI2 synthesis were found, except with 1000
muM LAA which inhibited cyclooxygenase activity after 24 h. In general
terms, OAA showed similar inhibitory effects on PGI2 production as di
d LAA, but with a shifted time course, since the production of PGI2 at
24 h for OAA was similar to that observed for LAA at 2 h. The release
of labeled arachidonic acid from cell membranes was significantly red
uced (75-85%), after 24 h, with both FAA. The effect of 100 muM LAA on
thrombin-induced PGI2 Production was rapid (within 15 min) and irreve
rsible after 60 min. The recovery of PGI2 synthesis after LAA treatmen
t was blocked by cycloheximide, suggesting a decrease of phospholipase
(s) activity or cessation of enzyme synthesis. Moreover, this reduced
PGI2 synthesis was not associated with [H-3]adenine release. Our data
indicate that FAA induce a significant impairment of stimulated PGI2 s
ynthesis and arachidonic acid release in endothelial cells, acting pri
marily as inhibitors of phospholipase(s) rather than of cyclooxygenase
. Finally, both LAA and OAA induce an anti-fibrinolytic activity in th
ese cells where major changes are observed in the plasminogen activato
r inhibitor and the urine-type plasminogen activator.